Why Oncology Deal Making Continues To Fuel Biotech M&A

By Bryan Luchs and Mike Weir · March 21, 2024, 6:03 PM EDT

Growing demand for cancer drugs, along with patent expiries and AI innovation, are driving deal making in the red-hot oncology space....

To view the full article, register now.